Unexo Life Sciences

Unexo Life Sciences is a private Indian healthcare products company focused on topical and transdermal patches and related consumer health products. The company manufactures and markets pain relief patches, menstrual cramp patches, fever cooling patches, vapor patches, disinfectant wipes, mosquito repellent patches, and acne patches, and it emphasizes in-house R&D, analytical testing, and vertically integrated manufacturing in Delhi. Unexo positions itself as a specialist in patch-based delivery and states that it supplies products in multiple international markets, including OEM and distribution relationships. The company appears to be commercial-stage rather than a clinical drug developer, with its business centered on marketed products and manufacturing capabilities rather than a disclosed therapeutic pipeline. Public FDA records show the company received a Warning Letter in November 2024 related to CGMP deficiencies at its New Delhi finished pharmaceuticals facility.